HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kowluru, R. A. Articles by Gierhart, D. L. Search for Related Content PubMed PubMed Citation Articles by Kowluru, R. A. Articles by Gierhart, D. L.

Beneficial Effect of Zeaxanthin on Retinal Metabolic Abnormalities in Diabetic Rats

¹From the Department of Ophthalmology, Kresge Eye Institute, Detroit, Michigan; and ²Zeavision, LLC, Chesterfield, Missouri.

PURPOSE. Oxidative damage and growth factors are implicated in the pathogenesis of retinopathy in diabetes. Recent studies have shown that two dietary carotenoids, lutein and zeaxanthin (Zx), that are specifically concentrated within ocular tissues, may play important roles in maintaining their integrity. This study is to evaluate the potential protective effects of Zx against retinal oxidative damage and growth factors in diabetes.

METHODS. A group of rats received normal powdered diet or powdered diet supplemented with 0.02% or 0.1% Zx soon after induction of diabetes. Age-matched normal rats served as control subjects. At 2 months of diabetes, oxidative stress, vascular endothelial cell growth factor (VEGF), and intercellular adhesion molecule (ICAM)-1 were quantified in the retina.

RESULTS. Zx supplementation prevented diabetes-induced increase in retinal damage, and increases in VEGF and ICAM-1. The levels of lipid peroxide, oxidatively modified DNA, electron transport complex III, nitrotyrosine, and mitochondrial superoxide dismutase were similar in the retinas of Zx-treated diabetic rats and normal control rats, and these values were significantly different from those obtained from diabetic rats without any supplementation. In the same rats, Zx also prevented diabetes-induced increases in retinal VEGF and ICAM-1. Both 0.02% and 0.1% Zx had similar effects on diabetes-induced retinal abnormalities, and these effects were achieved without ameliorating the severity of hyperglycemia. However, Zx administration failed to prevent a diabetes-induced decrease in retinal GSH levels.

CONCLUSIONS. Zx significantly inhibits diabetes-induced retinal oxidative damage and elevation in VEGF and adhesion molecule, all abnormalities that are associated with the pathogenesis of diabetic retinopathy. The results suggest that Zx supplementation has the potential to inhibit the development of retinopathy in diabetic patients.

This article has been cited by other articles:

				I. Domonkos, P. Malec, H. Laczko-Dobos, O. Sozer, K. Klodawska, H. Wada, K. Strzalka, and Z. Gombos Phosphatidylglycerol Depletion Induces an Increase in Myxoxanthophyll Biosynthetic Activity in Synechocystis PCC6803 Cells Plant Cell Physiol., February 1, 2009; 50(2): 374 - 382. [Abstract] [Full Text] [PDF]

				M. Kanwar and R. A. Kowluru Role of Glyceraldehyde 3-Phosphate Dehydrogenase in the Development and Progression of Diabetic Retinopathy Diabetes, January 1, 2009; 58(1): 227 - 234. [Abstract] [Full Text] [PDF]

				R. A. Kowluru, M. Kanwar, P.-S. Chan, and J. P. Zhang Inhibition of Retinopathy and Retinal Metabolic Abnormalities in Diabetic Rats With AREDS-Based Micronutrients Arch Ophthalmol, September 1, 2008; 126(9): 1266 - 1272. [Abstract] [Full Text] [PDF]